首页> 外文期刊>Journal of Clinical Pathology >Huerthle cell follicular carcinoma of the thyroid gland presenting with diffuse meningeal carcinomatosis and evolving to anaplastic carcinoma
【24h】

Huerthle cell follicular carcinoma of the thyroid gland presenting with diffuse meningeal carcinomatosis and evolving to anaplastic carcinoma

机译:甲状腺弥漫性脑膜癌并发展为间变性癌的甲状腺结节性滤泡性癌

获取原文
获取原文并翻译 | 示例
           

摘要

Huerthle cell follicular carcinoma (HCFC) of the thyroid gland is a malignant tumour composed predominantly or entirely of oncocytes (also called "Hiirthle" or "Askenazy" cells), arranged in a follicular/trabecular pattern without the cytological changes found in papillary carcinoma. Although most studies have demonstrated that HCFC and follicular thyroid carcinoma share similar clinical behaviour and prognosis, recently the World Health Organization (WHO) has classified HCFC as a separate and distinct entity. Anaplastic thyroid carcinoma accounts for 5-10% of all thyroid cancers and represents the most aggressive thyroid tumour almost invariably associated with a fatal outcome. Most anaplastic thyroid carcinoma cases show evidence of a preexisting differentiated, or poorly differentiated, thyroid carcinoma. At present, to our knowledge, the secondary leptomeningeal localisation of thyroid HCFC has not yet been reported in the literature.
机译:甲状腺的Huerthle细胞滤泡癌(HCFC)是一种恶性肿瘤,主要或全部由癌细胞(也称为“ Hiirthle”或“ Askenazy”细胞)组成,排列成滤泡/小梁的形式,而在乳头状癌中未发现细胞学变化。尽管大多数研究表明,HCFC和甲状腺滤泡癌具有相似的临床行为和预后,但最近世界卫生组织(WHO)已将HCFC归类为一个独立的实体。间变性甲状腺癌占所有甲状腺癌的5-10%,是最致命的甲状腺肿瘤,几乎总是与致命结局相关。大多数变性间变性甲状腺癌病例显示已存在分化或低分化甲状腺癌的证据。目前,据我们所知,文献中尚未报道甲状腺HCFC的继发性脑膜外定位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号